Eculizumab (Soliris), a drug to treat the rare red blood cell disorder paroxysymal nocturnal hemoglobinuria (PNH) manufactured by Alexion Pharmaceuticals is being sold at retail price of $409,500 for a year's treatment.

Cytokine interleukin 17E (IL-17E) has been found to effective in a number of solid tumors, including melanoma, breast, colon, pancreatic, and non-small cell lung cancers, Lorus Therapeutics Inc announced.

World's top drug maker Pfizer is reportedly in talks to buy a stake in India's leading generic firm Dr Reddy's Laboratories.

Combined use of anti-HIV drugs saquinavir and ritonavir may lead to serious heart problems, US FDA alerted in its latest safety report.

Waters has developed environment-friendly supercritical fluid chromatography (SFC) columns Viridis.

SensiGene Fetal(XY), a simple blood test to know the sex of the fetal baby by Sequenom Inc has been launched, the company announced in a press release.

Cayston, an inhalation solution of the antibiotic aztreonam, has been approved in US for the treatmant of cystic fibrosis patients with Pseudomonas aeruginosa, Gilead Sciences, Inc.  announced.

aura6000, a device to treat obstructive sleep apnea (OSA) developed by ImThera, is currently undergoing clinical trials in Belgium.

Bevacizumab (Avastin) by Roche has been found not effective to treat stomach cancer in a clinical study.

Anti-asthma drugs containing salmetrol could face tougher challenges in Indian market as US FDA has issued strong concern about the use of long-acting beta agonists (LABAs) to treat the disease.